Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)

Status:
Completed

Trial end date:
2008-01-01

Target enrollment:

Participant gender:

The study will test if the efficacy and safety of an alternative dosing regimen is as effective as monthly injections.

Phase 3

Novartis

Ranibizumab